MannKind Corp
NASDAQ: MNKD
$4.62
Closing price March 18, 2024
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Published:
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Published:
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published: